BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19781306)

  • 1. Vascular brachytherapy revisited for in-stent restenosis in the drug-eluting stent era: current status and future perspective.
    Li XJ; Rha SW; Wani SP; Wang L; Poddar KL; Oh DJ
    Chin Med J (Engl); 2009 Sep; 122(18):2174-9. PubMed ID: 19781306
    [No Abstract]   [Full Text] [Related]  

  • 2. [Balloon angioplasty for the treatment of the drug-eluting stent restenosis in a patient with multivessel coronary artery disease and muscular bridge].
    Pawłowski T; Kulawik T; Rzezak J
    Kardiol Pol; 2008 Nov; 66(11):1229-31; discussion 1232. PubMed ID: 19105104
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary brachytherapy in the drug-eluting stent era: don't bury it alive.
    Waksman R; Weinberger J
    Circulation; 2003 Jul; 108(4):386-8. PubMed ID: 12885731
    [No Abstract]   [Full Text] [Related]  

  • 4. Preventing restenosis in early drug-eluting stent era: recent developments and future perspectives.
    Birkenhauer P; Yang Z; Gander B
    J Pharm Pharmacol; 2004 Nov; 56(11):1339-56. PubMed ID: 15525440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary revascularisation following intracoronary brachytherapy.
    Sabaté M
    EuroIntervention; 2009 May; 5 Suppl D():D121-6. PubMed ID: 19736060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular brachytherapy: applications in the era of drug-eluting stents.
    Waksman R
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S23-30. PubMed ID: 12478232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
    Ducrocq G; Serebruany V; Tanguay JF
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and safety of intra-coronary Beta irradiation with 144Ce/Pr for prevention of restenosis after percutaneous transluminal coronary angioplasty of in-stent restenotic lesions.
    Bonvini RF; Hendiri T; Leo G; Aeby N; Noble J; Sigwart U; Verin V
    Acute Card Care; 2006; 8(4):217-23. PubMed ID: 17162548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late in-stent restenosis in a patient with drug-eluting stent.
    Sultan FA; Kazmi K; Dhakam S; Quraishi AU
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):648-9. PubMed ID: 19810309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maximizing benefit of drug-eluting stent by direct coronary stenting because of further reduction of inflammatory response.
    Li JJ; Gao RL
    Chin Med J (Engl); 2009 Mar; 122(6):732-5. PubMed ID: 19323943
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-eluting stents: a critique.
    Melikian N; Wijns W
    Heart; 2008 Feb; 94(2):145-52. PubMed ID: 18195121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment and prevention of restenosis after percutaneous coronary intervention. Balloons, stents, radioactive rays and drug-releasing stents].
    Maeng M; Thuesen L; Andersen HR
    Ugeskr Laeger; 2005 Aug; 167(33):3030-2. PubMed ID: 16109244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-eluting stents and other anti-restenosis devices].
    Moreno R
    Rev Esp Cardiol; 2005 Jul; 58(7):842-62. PubMed ID: 16022816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stent safety.
    Slottow TL; Waksman R
    Am J Cardiol; 2007 Oct; 100(8B):10M-17M. PubMed ID: 17950827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label use of drug-eluting stents putting it in perspective.
    Grines CL
    J Am Coll Cardiol; 2008 Feb; 51(6):615-7. PubMed ID: 18261679
    [No Abstract]   [Full Text] [Related]  

  • 16. Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.
    Agema WR; Monraats PS; Zwinderman AH; De Winter RJ; Tio RA; Doevendans PA; Waltenberger J; De Maat MP; Frants RR; Atsma DE; Van Der Laarse A; Van Der Wall EE; Jukema JW
    Eur Heart J; 2004 Jul; 25(13):1163-70. PubMed ID: 15231375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value and limitations of target-vessel ischemia in predicting late clinical events after drug-eluting stent implantation.
    Zellweger MJ; Kaiser C; Brunner-La Rocca HP; Buser PT; Osswald S; Weiss P; Mueller-Brand J; Pfisterer ME;
    J Nucl Med; 2008 Apr; 49(4):550-6. PubMed ID: 18344439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards defining the role of drug eluting stents.
    Tarantini G; Ramondo A; Razzolini R
    Minerva Cardioangiol; 2008 Feb; 56(1):29-34. PubMed ID: 18432166
    [No Abstract]   [Full Text] [Related]  

  • 19. Paclitaxel-eluting balloon: from bench to bed.
    De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stent thrombosis.
    Steinberg DH; Satler LF
    Minerva Cardioangiol; 2008 Feb; 56(1):127-37. PubMed ID: 18432175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.